Clinical Trial

Diabetes Interventional Assessment of Slimming or Training to Lessen Inconspicuous Cardiovascular Dysfunction

Study acronym: Diastolic
Recruiting
View on ClinicalTrials.gov →
Summary
There is an epidemic of type 2 diabetes in younger adults. These patients are at very high lifetime risk of heart-related complications. Subtle heart abnormalities can be present even at a young age in these patients and may predispose them to heart failure and ultimately premature death. There is emerging evidence that type 2 diabetes can be reversed with weight loss. We propose that weight loss can also reverse the fatty changes seen in the liver and heart in these patients, and in turn lead to improved heart function. This project aims to identify how type 2 diabetes causes changes in the heart in young people with type 2 diabetes by performing detailed scans and other tests of the heart's structure and function. In addition we will attempt to see if the heart's pumping function can be improved, either by a weight loss program with a special low calorie diet, or by a structured program of exercise. This will be compared with the usual standard diabetes care. As well as looking to see if the heart's function can be improved with the intervention, we also aim to identify what the mechanism of any improvement would be. We suspect that changes in the amount of fat within the liver and the heart may be responsible, and will measure these at the beginning, end and in some patients halfway through the study to explore possible mechanisms amongst other clinical variables (e.g. HbA1c)
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2015-10-28; most recent amendment 2024-01-03.
Status change: Active, Not Recruiting → Recruiting 2024-01-03
Status change: Recruiting → Active, Not Recruiting 2019-05-20
Status change: Not Yet Recruiting → Recruiting 2016-11-21
Trial Details
NCT Number NCT02590822
Lead Sponsor University of Leicester
Collaborators: University Hospitals, Leicester, National Institute for Health Research, United Kingdom
Conditions Diabetes
Enrollment 120 participants
Start Date 2015-10-02
Primary Completion 2028-08-31 (estimated)
Study Completion 2028-08-31 (estimated)
Updated on ClinicalTrials.gov 2024-01-05